Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease

Joseph M. Kim; Deepak L. Bhatt; Samuel Dagogo-Jack; David Z.I. Cherney; Francesco Cosentino; Darren K. McGuire; Richard E. Pratley; Chih Chin Liu; Nilo B. Cater; Robert Frederich; James P. Mancuso; Christopher P. Cannon

doi:10.1111/dom.14965

Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease

Joseph M. Kim
, Deepak L. Bhatt
, Samuel Dagogo-Jack
, David Z.I. Cherney
, Francesco Cosentino
, Darren K. McGuire
, Richard E. Pratley
, Chih Chin Liu
, Nilo B. Cater
, Robert Frederich
, James P. Mancuso
, Christopher P. Cannon

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	1398-1402
Number of pages	5
Journal	Diabetes, Obesity and Metabolism
Volume	25
Issue number	5
DOIs	https://doi.org/10.1111/dom.14965
State	Published - May 2023
Externally published	Yes

Keywords

REDUCE-IT
VERTIS CV
cardiovascular risk reduction
icosapent ethyl
type 2 diabetes

Access to Document

10.1111/dom.14965

Cite this

Kim, J. M., Bhatt, D. L., Dagogo-Jack, S., Cherney, D. Z. I., Cosentino, F., McGuire, D. K., Pratley, R. E., Liu, C. C., Cater, N. B., Frederich, R., Mancuso, J. P., & Cannon, C. P. (2023). Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease. Diabetes, Obesity and Metabolism, 25(5), 1398-1402. https://doi.org/10.1111/dom.14965

@article{f986bdf5ffbd4df38071437bf0d0f096,

title = "Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease",

keywords = "REDUCE-IT, VERTIS CV, cardiovascular risk reduction, icosapent ethyl, type 2 diabetes",

author = "Kim, \{Joseph M.\} and Bhatt, \{Deepak L.\} and Samuel Dagogo-Jack and Cherney, \{David Z.I.\} and Francesco Cosentino and McGuire, \{Darren K.\} and Pratley, \{Richard E.\} and Liu, \{Chih Chin\} and Cater, \{Nilo B.\} and Robert Frederich and Mancuso, \{James P.\} and Cannon, \{Christopher P.\}",

year = "2023",

month = may,

doi = "10.1111/dom.14965",

language = "English",

volume = "25",

pages = "1398--1402",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "John Wiley and Sons Inc.",

number = "5",

}

Kim, JM, Bhatt, DL, Dagogo-Jack, S, Cherney, DZI, Cosentino, F, McGuire, DK, Pratley, RE, Liu, CC, Cater, NB, Frederich, R, Mancuso, JP & Cannon, CP 2023, 'Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease', Diabetes, Obesity and Metabolism, vol. 25, no. 5, pp. 1398-1402. https://doi.org/10.1111/dom.14965

Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease. / Kim, Joseph M.; Bhatt, Deepak L.; Dagogo-Jack, Samuel et al.
In: Diabetes, Obesity and Metabolism, Vol. 25, No. 5, 05.2023, p. 1398-1402.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Potential for residual cardiovascular risk reduction

T2 - Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease

AU - Kim, Joseph M.

AU - Bhatt, Deepak L.

AU - Dagogo-Jack, Samuel

AU - Cherney, David Z.I.

AU - Cosentino, Francesco

AU - McGuire, Darren K.

AU - Pratley, Richard E.

AU - Liu, Chih Chin

AU - Cater, Nilo B.

AU - Frederich, Robert

AU - Mancuso, James P.

AU - Cannon, Christopher P.

PY - 2023/5

Y1 - 2023/5

KW - REDUCE-IT

KW - VERTIS CV

KW - cardiovascular risk reduction

KW - icosapent ethyl

KW - type 2 diabetes

UR - https://www.scopus.com/pages/publications/85148295248

U2 - 10.1111/dom.14965

DO - 10.1111/dom.14965

M3 - Letter

C2 - 36594154

AN - SCOPUS:85148295248

SN - 1462-8902

VL - 25

SP - 1398

EP - 1402

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

IS - 5

ER -